Table 4.
Maternal, pregnancy, and neonatal outcomes for 8 deliveries among severe acute respiratory syndrome coronavirus 2–infected pregnant patients
| Characteristics | Deliveries (n=8)a |
|---|---|
| Delivery characteristics | |
| Gestational age at delivery | 38.4 (37.5–39.8) |
| Preterm birth | 1 (12.5) |
| Labor | |
| None | 2 (25.0) |
| Spontaneousb | 2 (25.0) |
| Inducedc | 4 (50.0) |
| Outcome | |
| Live birth | 7 (87.5) |
| Stillbirth | 1 (12.5) |
| Delivery route | |
| Vaginal | 5 (62.5) |
| Cesareand | 3 (37.5) |
| Complications | |
| Pregnancy | |
| Gestational diabetese | 1 (12.5) |
| Gestational hypertensionf | 2 (25.0) |
| Cholestasis | 1 (12.5) |
| Delivery | |
| Placental abruption | 1 (12.5) |
| Nonreassuring fetal status or fetal distress | 3 (37.5) |
| Postpartum | |
| Postpartum preeclampsia with severe featuresg | 2 (25.0) |
| SARS-CoV-2 testing | |
| Days between positive test and delivery | 7.5 (5.0–11.5) |
COVID-19, coronavirus disease 2019; IQR, interquartile range; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Lokken et al. COVID-19 in pregnant women in Washington State. Am J Obstet Gynecol 2020.
Characteristics summarized as n (%) or median (IQR).
One patient with spontaneous onset of labor had labor subsequently augmented.
Reasons for inductions included fetal demise (n=1), premature rupture of membranes (n=1), diabetes mellitus (n=1), hypertensive disorders of pregnancy (n=1), growth restrictions (n=1), and scheduled induction (n=2). No inductions of labor were performed to improve maternal lung function.
Cesarean delivery indications included (multiple indications in some cases) repeat cesarean delivery (n=2), nonreassuring fetal status (n=1), diabetes mellitus (n=1), respiratory compromise (n=1), second-stage arrest (n=1), malpresentation (n=1), COVID-19 (n=2) (decision in the context of COVID-19 and other comorbidities [n=1] and worsening respiratory status [n=1]), and others (n=1) (cholestasis, history of shoulder dystocia, fetal macrosomia in the current pregnancy).
Treated with insulin.
Diagnosed concurrently with (n=1) or after positive SARS-CoV-2 test (n=1).
Both cases were defined as severe by blood pressure criteria.